Endotoxin tolerance attenuates airway allergic inflammation in model mice by suppression of the t-cell stimulatory effect of dendritic cells

International Immunology

Volumn 22, Issue 9, 2010, Pages 739-747

  Matsushita, Hidetomo ^a   Ohta, Shoichiro ^a   Shiraishi, Hiroshi ^a   Suzuki, Shoichi ^a   Arima, Kazuhiko ^a   Toda, Shuji ^a   Tanaka, Hiroyuki ^b   Nagai, Hiroichi ^b   Kimoto, Masao ^a   Inokuchi, Akira ^a   Izuhara, Kenji ^a  

^a SAGA UNIVERSITY   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Bronchial asthma; Hygiene hypothesis; Lipopolysaccharide; Th2; Toll like receptor 4

Indexed keywords

OVALBUMIN; TOLL LIKE RECEPTOR 4;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENDOTOXIN TOLERANCE; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ASTHMA; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENDOTOXINS; HUMANS; IMMUNE TOLERANCE; MICE; MICE, INBRED BALB C; OVALBUMIN; TH17 CELLS; TH2 CELLS; TOLL-LIKE RECEPTOR 4;

EID: 77956113956     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxq062     Document Type: Article

References (43)

1. Biswas, S. K. and Lopez-Collazo, E. 2009. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30:475.
2. Buckley, J. M., Wang, J. H. and Redmond, H. P. 2006. Cellular reprogramming by gram-positive bacterial components: a review. J. Leukoc. Biol. 80:731.
3. Fujihara, M., Muroi, M., Tanamoto, K., Suzuki, T., Azuma, H. and Ikeda, H. 2003. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol. Ther. 100:171.
4. Wolk, K., Döcke, W. D., von Baehr, V., Volk, H. D. and Sabat, R. 2000. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 96:218.
5. Wolk, K., Kunz, S., Crompton, N. E., Volk, H. D. and Sabat, R. 2003. Multiple mechanisms of reduced major histocompatibility complex class II expression in endotoxin tolerance. J. Biol. Chem. 278:18030.
6. Muthukuru, M. and Cutler, C. W. 2008. Antigen capture of Porphyromonas gingivalis by human macrophages is enhanced but killing and antigen presentation are reduced by endotoxin tolerance. Infect. Immun. 76:477.
7. del Fresno, C., Garcia-Rio, F., Gomez-Pina, V. et al. 2009. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. J. Immunol. 182:6494.
8. Monneret, G., Finck, M. E., Venet, F. et al. 2004. The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol. Lett. 95:193.
9. del Fresno, C., Gomez-Pina, V., Lores, V. et al. 2008. Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: down-regulation of TREM-1 as putative underlying mechanism. PLoS One 3:e2667.
10. del Fresno, C., Soler-Rangel, L., Soares-Schanoski, A. et al. 2007. Inflammatory responses associated with acute coronary syndrome up-regulate IRAK-M and induce endotoxin tolerance in circulating monocytes. J. Endotoxin Res. 13:39.
11. Holgate, S. T. 1999. The epidemic of allergy and asthma. Nature 402:B2.
12. Wills-Karp, M., Santeliz, J. and Karp, C. L. 2001. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat. Rev. Immunol. 1:69.
13. Strachan, D. P. 1989. Hay fever, hygiene, and household size. BMJ 299:1259.
14. Braun-Fahrlander, C., Riedler, J., Herz, U. et al. 2002. Environmental exposure to endotoxin and its relation to asthma in schoolage children. N. Engl. J. Med. 347:869.
15. Gereda, J. E., Leung, D. Y., Thatayatikom, A. et al. 2000. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet 355:1680.
16. Ege, M. J., Bieli, C., Frei, R. et al. 2006. Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children. J. Allergy Clin. Immunol. 117:817.
17. Tavernier, G., Fletcher, G., Gee, I. et al. 2006. IPEADAM study: indoor endotoxin exposure, family status, and some housing characteristics in English children. J. Allergy Clin. Immunol. 117:656.
18. Thorne, P. S., Kulhánková, K., Yin, M., Cohn, R., Arbes, S. Jr and Zeldin, D. C. 2005. Endotoxin exposure is a risk factor for asthma: the national survey of endotoxin in United States housing. Am. J. Respir. Crit. Care Med. 172:1371.
19. Park, J. H., Gold, D. R., Spiegelman, D. L., Burge, H. A. and Milton, D. K. 2001. House dust endotoxin and wheeze in the first year of life. Am. J. Respir. Crit. Care Med. 163:322.
20. Revets, H., Pynaert, G., Grooten, J. and De Baetselier, P. 2005. Lipoprotein I, a TLR2/4 ligand modulates Th2-driven allergic immune responses. J. Immunol. 174:1097.
21. Kuipers, H., Hijdra, D., De Vries, V. C. et al. 2003. Lipopolysaccharide-induced suppression of airway Th2 responses does not require IL-12 production by dendritic cells. J. Immunol. 171:3645.
22. Rodriguez, D., Keller, A. C., Faquim-Mauro, E. L. et al. 2003. Bacterial lipopolysaccharide signaling through Toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity. J. Immunol. 171:1001.
23. Vannier, E., Lefort, J., Lellouch-Tubiana, A., Terlain, B. and Vargaftig, B. B. 1991. Lipopolysaccharide from Escherichia coli reduces antigen-induced bronchoconstriction in actively sensitized guinea pigs. J. Clin. Invest. 87:1936.
24. Hammad, H., Chieppa, M., Perros, F., Willart, M. A., Germain, R. N. and Lambrecht, B. N. 2009. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat. Med. 15:410.
25. Trompette, A., Divanovic, S., Visintin, A. et al. 2009. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 457:585.
26. Eisenbarth, S. C., Piggott, D. A., Huleatt, J. W., Visintin, I., Herrick, C. A. and Bottomly, K. 2002. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196:1645.
27. Vercelli, D. 2006. Mechanisms of the hygiene hypothesis-molecular and otherwise. Curr. Opin. Immunol. 18:733.
28. Gerhold, K., Blumchen, K., Bock, A. et al. 2002. Endotoxins prevent murine IgE production, T(H)2 immune responses, and development of airway eosinophilia but not airway hyperreactivity. J. Allergy Clin. Immunol. 110:110.
29. Wang, Y. and McCusker, C. 2006. Neonatal exposure with LPS and/or allergen prevents experimental allergic airways disease: development of tolerance using environmental antigens. J. Allergy Clin. Immunol. 118:143.
30. Zuany-Amorim, C., Sawicka, E., Manlius, C. et al. 2002. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat. Med. 8:625.
31. Ohta, S., Bahrun, U., Shimazu, R., Matsushita, H., Fukudome, K. and Kimoto, M. 2006. Induction of long-term lipopolysaccharide tolerance by an agonistic monoclonal antibody to the toll-like receptor 4/MD-2 complex. Clin. Vaccine Immunol. 13:1131.
32. Lu, M., Varley, A. W., Ohta, S., Hardwick, J. and Munford, R. S. 2008. Host inactivation of bacterial lipopolysaccharide prevents prolonged tolerance following gram-negative bacterial infection. Cell Host Microbe 4:293.
33. Nakao, I., Kanaji, S., Ohta, S. et al. 2008. Identification of pendrin as a common mediator for mucus production in bronchial asthma and chronic obstructive pulmonary disease. J. Immunol. 180: 6262.
34. Hawrylowicz, C. M. and O'Garra, A. 2005. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat. Rev. Immunol. 5:271.
35. Akdis, M., Blaser, K. and Akdis, C. A. 2005. T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J. Allergy Clin. Immunol. 116:961.
36. 3+ regulatory T cell function. Science 322:271.
37. Polte, T., Foell, J., Werner, C. et al. 2006. CD137-mediated immunotherapy for allergic asthma. J. Clin. Invest. 116:1025.
38. Akdis, C. A., Joss, A., Akdis, M., Faith, A. and Blaser, K. 2000. A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding. FASEB J. 14:1666.
39. Chen, X. Q., Yang, J., Hu, S. P., Nie, H. X., Mao, G. Y. and Chen, H. B. 2006. Increased expression of CD86 and reduced production of IL-12 and IL-10 by monocyte-derived dendritic cells from allergic asthmatics and their effects on Th1-and Th2-type cytokine balance. Respiration 73:34.
40. Shi, H. Z., Xie, Z. F., Deng, J. M., Chen, Y. Q. and Xiao, C. Q. 2004. Soluble CD86 protein in serum samples of patients with asthma. Thorax 59:870.
41. Wong, C. K., Lun, S. W., Ko, F. W., Ip, W. K., Hui, D. S. and Lam, C. W. 2005. Increased expression of plasma and cell surface costimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma. Clin. Exp. Immunol. 141:122.
42. Bach, J. F. 2002. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347:911.
43. Fonseca, D. E. and Kline, J. N. 2009. Use of CpG oligonucleotides in treatment of asthma and allergic disease. Adv. Drug Deliv. Rev. 61:256.